TITLE
Predicting Response and Survival in Chemotherapy-Treated Triple-Negative Breast Cancer

ORGANISM
Homo sapiens

SUMMARY
Gene expression data of pre-treatment samples of GEICAM2006-03 TNBC trial Patients were randomized to carboplatin or no carboplatin in the neoadjuvant setting

DESIGN
In the study presented here, a well-defined cohort of 69 breast samples were used to acquire expression profiles of a total of 543 unique genes (+5 HK genes)

PLATFORM
GPL18800 NanoString nCounter Nano548 Gene Expression Custom CodeSet

CITATIONS
25101563

